Investor presentation March 2024
Find out more ➝
Investor presentation March 2024
Find out more ➝
Proteomics International signs agreement with University of Oxford to further validate 'PromarkerEndo' test for endometriosis
Find out more ➝
European patent granted for OxiDx technology
Find out more ➝
US Medicare confirms reimbursement price for PromarkerD
Find out more ➝
Proteomics’ new oesophageal cancer test presented at global conference
Find out more ➝